The biodefense market is expected to grow at CAGR of 4.8% to reach USD 6.53 billion by 2025.

Biodefense includes medical procedures in order to give precaution to individuals against bio terrorism. Biodefense is a very important industry. It is known for engineering counter actions for biological threats. It is also used to prepare for bio-incidents. At the same time, it is used for military measures to ensure bio security. Biodefense is needed for two different groups which include military professionals who are combatant and civilians who are non-combatant.

The market growth is based completely on the government strategies and budget allowances of different countries around the world. However, a lot of organisations are working towards the countermeasures of various biological threats. Also, the world politics is a dangerous game and hence, the need for biodefense is said to increase rapidly after every passing year. Organisations like Biomedical Advanced Research and Development Authority (BARDA), Centres for Disease Control and Prevention (CDC), the Department of Defense (DoD) and the United States Department of Health & Human Services (HHS) are actively working with this industry. The industry has a lot of potential and is expected to grow by USD XX Million by 2025

Browse 125 Tables and 100 Figures spread through over 150 Pages and in-depth TOC on “ Biodefense Market, By Product (Smallpox, Anthrax, Radiation/Nuclear, Botulism, Detectors/Triggering Devices, Samplers, Identifiers, Assays, and Reagents), and Geography (North America, Europe, Asia Pacific, Latin America and MEA) – Analysis, Share, Trends, Size, & Forecast from 2019 – 2025“

Request report sample here 

Key Takeaways

• The biodefense industry is categorised between vaccines and bio threat detection devices. The vaccinations are further divided by diseases like Botulism, Smallpox, nuclear and radiation threats and Anthrax.
• Anthrax and small pox are said to cause the highest destruction and thus, they are the key components of research under the biodefense industry. Anthrax has the highest per cent of share in the worldwide market with XX as of 2019 because of the rising investments by the U.S government.
• Biodefense samplers are used for the biological sampling, transport packaging, reducing waste and speeding up the sampling time.
• North America captures the highest share of the worldwide biodefense market with a total of 70%. This is because the U.S military and civilian agencies invest a lot in the research and development of this industry.
• The key players of this market includes Xoma Corporation, Dynport Vaccine Company, SIGA Technologies, Inc., SIGA Technologies, Inc., and Alnylam Pharmaceuticals, Inc. A lot of companies are merging to create different immunotherapy vaccines.

KEY BENEFITS OF THE REPORT:

• Understanding of the strategies that are being adopted by the key players in this market to stay competitive
• Extensive analysis of the key players dominating the competitive landscape of this market
• In-depth analysis of the key factors are propelling the growth of the global market
• Detailed analysis of the geographic region that will witness the strongest growth
• Granular analysis of the current market scenario and the expected market grow

The scope of this report covers the market by its major segments, which include as follows:

KEY PLAYERS

• Dynavax Technologies
• Xoma Corporation
• Emergent BioSolutions, Inc.
• SIGA Technologies, Inc.
• PharmAthene, Inc.
• Elusys Therapeutics, Inc.
• Dynport Vaccine Company
• Bavarian Nordic
• Ichor Medical Systems
• Cleveland Biolabs
• Nanotherapeutics, Inc.
• Achaogen, Inc.
• Alnylam Pharmaceuticals, Inc.

MARKET, BY PRODUCT

• Vaccines
  • Smallpox
  • Anthrax
  • Radiation/Nuclear
  • Botulism
• Biothreat Detection Devices
  • Samplers
  • Identifiers
  • Assays
  • Reagents
  • Detectors/Triggering Devices

MARKET, BY REGION

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
• Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Singapore
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Rest of MEA